Doximity Net Income 2020-2025 | DOCS
Doximity annual/quarterly net income history and growth rate from 2020 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Doximity net income for the quarter ending March 31, 2025 was $0.062B, a 53.77% increase year-over-year.
- Doximity net income for the twelve months ending March 31, 2025 was $0.223B, a 51.23% increase year-over-year.
- Doximity annual net income for 2025 was $0.223B, a 51.23% increase from 2024.
- Doximity annual net income for 2024 was $0.148B, a 30.81% increase from 2023.
- Doximity annual net income for 2023 was $0.113B, a 15.34% decline from 2022.
| Doximity Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $223 |
| 2024 | $148 |
| 2023 | $113 |
| 2022 | $133 |
| 2021 | $22 |
| 2020 | $11 |
| 2019 | $1 |
| Doximity Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $62 |
| 2024-12-31 | $75 |
| 2024-09-30 | $44 |
| 2024-06-30 | $41 |
| 2024-03-31 | $41 |
| 2023-12-31 | $48 |
| 2023-09-30 | $31 |
| 2023-06-30 | $28 |
| 2023-03-31 | $31 |
| 2022-12-31 | $33 |
| 2022-09-30 | $26 |
| 2022-06-30 | $22 |
| 2022-03-31 | $31 |
| 2021-12-31 | $56 |
| 2021-09-30 | $36 |
| 2021-06-30 | $11 |
| 2021-03-31 | $21 |
| 2020-12-31 | $5 |
| 2020-09-30 | $2 |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.431B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
| Hims & Hers Health (HIMS) | United States | $10.838B | 112.61 |
| Tempus AI (TEM) | United States | $10.042B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.445B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.743B | 58.48 |
| Hinge Health (HNGE) | United States | $3.360B | 0.00 |
| Privia Health (PRVA) | United States | $2.603B | 177.92 |
| Enovis (ENOV) | United States | $1.886B | 10.52 |
| Phreesia (PHR) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.514B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| 10x Genomics (TXG) | United States | $1.468B | 0.00 |
| Azenta (AZTA) | United States | $1.439B | 66.87 |
| Evolent Health (EVH) | United States | $1.367B | 116.40 |
| Omnicell (OMCL) | United States | $1.355B | 23.90 |
| Claritev (CTEV) | United States | $0.794B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.486B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
| Talkspace (TALK) | United States | $0.443B | 132.50 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| TruBridge (TBRG) | United States | $0.340B | 754.67 |
| Health Catalyst (HCAT) | United States | $0.275B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.268B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.217B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.075B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |